Comparison of Air and Expansile Gas in Pneumatic Retinopexy
NCT ID: NCT00120445
Last Updated: 2012-03-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
126 participants
INTERVENTIONAL
2004-07-31
2007-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Air Tamponade Versus Fluorinated Gas Tamponade for Rhegmatogenous Retinal Detachment
NCT07034469
Pneumatic Retinopexy Versus Vitrectomy for Retinal Detachment in Patients With Extended Criteria
NCT02871531
Pneumatic Retinopexy for Primary Rhegmatogenous Retinal Detachment: To Steamroll or Not
NCT04723420
Pneumatic Retinopexy Versus Vitrectomy With Gas for Retinal Detachment Due to Myopic Macular Hole
NCT00485199
Corneal Endothelial Cell Loss After Pneumatic Retinopexy for the Repair of Primary Rhegmatogenous Retinal Detachment
NCT02185469
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
2
air vs perfluoropropane gas in pneumatic retinopexy
air
0.3 ml of filtered air
expansile gas
0.3 ml of perfluoropropane gas
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
air
0.3 ml of filtered air
expansile gas
0.3 ml of perfluoropropane gas
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Single retinal break not greater than 2.5 clock hours in size
* Multiple breaks not greater than 3 clock hours away
* No (or minimal) proliferative vitreoretinopathy
* Physically and mentally co-operated in post-operative head positioning
* Signed informed consent form for the study
Exclusion Criteria
* Advanced glaucoma
* Aphakia or pseudophakia
* Previous ocular surgeries
* One-eyed patients
* Subject did not sign informed consent form
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Thailand Research Fund
OTHER
Khon Kaen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yosanan Yospaiboon
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yosanan Yospaiboon, M.D.
Role: PRINCIPAL_INVESTIGATOR
Khon Kaen University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eye outpatients department, Srinagarind Hospital, Khon Kaen University
Khon Kaen, Changwat Khon Kaen, Thailand
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Sinawat S, Ratanapakorn T, Sanguansak T, Prompol S, Laopaiboon M, Yospaiboon Y. Air vs perfluoropropane gas in pneumatic retinopexy: a randomized noninferiority trial. Arch Ophthalmol. 2010 Oct;128(10):1243-7. doi: 10.1001/archophthalmol.2010.230.
Schwartz SG, Flynn HW Jr, Wang X, Kuriyan AE, Abariga SA, Lee WH. Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy. Cochrane Database Syst Rev. 2020 May 13;5(5):CD006126. doi: 10.1002/14651858.CD006126.pub4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TRF470116
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
HE470116
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.